IRONWOOD PHARMACEUTICALS, INC. (IRWD)

4.13 -2.59% (-0.11)

Over 1Y: +212.9%

2026-08-28
Style
Area Line Line with markers Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2 4
Aug Oct Dec Feb Apr Jun Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 103.7M Q3 '21 — Operating Cash Flow: 75.1M Q3 '21 — Net Income: 55.8M Q4 '21 — Revenue: 117.1M Q4 '21 — Operating Cash Flow: 64.6M Q4 '21 — Free Cash Flow: 64.4M Q4 '21 — Net Income: 41.4M Q1 '22 — Revenue: 97.5M Q1 '22 — Operating Cash Flow: 64.1M Q1 '22 — Free Cash Flow: 64.1M Q1 '22 — Net Income: 38.8M Q2 '22 — Revenue: 97.2M Q2 '22 — Operating Cash Flow: 61.4M Q2 '22 — Free Cash Flow: 61.3M Q2 '22 — Net Income: 37.1M Q3 '22 — Revenue: 108.6M Q3 '22 — Operating Cash Flow: 69.1M Q3 '22 — Free Cash Flow: 69M Q3 '22 — Net Income: 50.3M Q4 '22 — Revenue: 107.2M Q4 '22 — Operating Cash Flow: 79.2M Q4 '22 — Net Income: 48.9M Q1 '23 — Revenue: 104.1M Q1 '23 — Operating Cash Flow: 80.2M Q1 '23 — Free Cash Flow: 80.2M Q1 '23 — Net Income: 45.7M Q2 '23 — Revenue: 107.4M Q2 '23 — Operating Cash Flow: 35M Q2 '23 — Free Cash Flow: 35M Q2 '23 — Net Income: -1.1B Q3 '23 — Revenue: 113.7M Q3 '23 — Operating Cash Flow: 32.5M Q3 '23 — Free Cash Flow: 32.4M Q3 '23 — Net Income: 15.3M Q4 '23 — Revenue: 117.6M Q4 '23 — Operating Cash Flow: 35.8M Q4 '23 — Free Cash Flow: 35.6M Q4 '23 — Net Income: -1.1M Q1 '24 — Revenue: 74.9M Q1 '24 — Operating Cash Flow: 45M Q1 '24 — Free Cash Flow: 44.9M Q1 '24 — Net Income: -4.2M Q2 '24 — Revenue: 94.4M Q2 '24 — Operating Cash Flow: 33.5M Q2 '24 — Free Cash Flow: 33.4M Q2 '24 — Net Income: -860K Q3 '24 — Revenue: 91.6M Q3 '24 — Operating Cash Flow: 9.9M Q3 '24 — Free Cash Flow: 9.9M Q3 '24 — Net Income: 3.6M Q4 '24 — Revenue: 90.5M Q4 '24 — Operating Cash Flow: 15.2M Q4 '24 — Free Cash Flow: 15.2M Q4 '24 — Net Income: 2.3M Q1 '25 — Revenue: 41.1M Q1 '25 — Operating Cash Flow: 20M Q1 '25 — Free Cash Flow: 19.9M Q1 '25 — Net Income: -37.4M Q2 '25 — Revenue: 85.2M Q2 '25 — Operating Cash Flow: -15.1M Q2 '25 — Free Cash Flow: -15.1M Q2 '25 — Net Income: 23.6M Q3 '25 — Revenue: 122.1M Q3 '25 — Operating Cash Flow: 47.6M Q3 '25 — Free Cash Flow: 47.6M Q3 '25 — Net Income: 40.1M Q4 '25 — Revenue: 47.7M Q4 '25 — Operating Cash Flow: 74.6M Q4 '25 — Free Cash Flow: 74.6M Q4 '25 — Net Income: -2.3M Q1 '26 — Revenue: 106.5M Q1 '26 — Operating Cash Flow: 5.1M Q1 '26 — Net Income: 40.8M Q2 '26 — Revenue: 113M Q2 '26 — Operating Cash Flow: 58.3M Q2 '26 — Net Income: 51.3M -1B -750M -500M -250M 0 250M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

9.8
OE margin 44.0%
Oper. margin 60.1%
ROIC —
Accruals -19.5%
Capex / sales 0.0087%
FCF margin 47.7%
OCF margin 47.7%
ROA 45.5%
ROCE 92.8%
OCF / EBIT 0.79×
Gross margin —
ROE —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales 0.0032×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.5
ND/EBITDA —
Debt payback 0.0 yr
Payout 0.0%
Quick ratio 6.0×
F-score 5.1 pts
Cash / Debt —
Cash runway —
Debt / Eq —
Equity / Assets —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.2
Sales/sh Y/Y +23.9%
EBIT Y/Y +219.3%
Sales Q/Q +32.6%
EBIT CAGR -1.9%
Div. growth —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.